Cytokine receptor zcytor17
CA 2412239 C · Owner: Gao, Zeren · Inventors: Maurer, Mark F.; Whitmore, Theodore E.; Gao, Zeren
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel polypeptides, polynucleotides encoding the polypeptides and related , compositions and methods are disclosed for zcytor17 a novel cytokine , receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic lymphoid , and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro andin vivo. The polynucleotides encoding zcytor17, are located on chromosome 5 and can be , used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein uses , therefor and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 2001 and granted May 28, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.